Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jan 1;183(1):1–5. doi: 10.1084/jem.183.1.1

Sorting out the cytokines of asthma

PMCID: PMC2192428  PMID: 8551212

Full Text

The Full Text of this article is available as a PDF (522.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balsinde J., Barbour S. E., Bianco I. D., Dennis E. A. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11060–11064. doi: 10.1073/pnas.91.23.11060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bousquet J., Chanez P., Lacoste J. Y., Barnéon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P. Eosinophilic inflammation in asthma. N Engl J Med. 1990 Oct 11;323(15):1033–1039. doi: 10.1056/NEJM199010113231505. [DOI] [PubMed] [Google Scholar]
  3. Bradding P., Feather I. H., Howarth P. H., Mueller R., Roberts J. A., Britten K., Bews J. P., Hunt T. C., Okayama Y., Heusser C. H. Interleukin 4 is localized to and released by human mast cells. J Exp Med. 1992 Nov 1;176(5):1381–1386. doi: 10.1084/jem.176.5.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradding P., Okayama Y., Howarth P. H., Church M. K., Holgate S. T. Heterogeneity of human mast cells based on cytokine content. J Immunol. 1995 Jul 1;155(1):297–307. [PubMed] [Google Scholar]
  5. Broide D. H., Gleich G. J., Cuomo A. J., Coburn D. A., Federman E. C., Schwartz L. B., Wasserman S. I. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol. 1991 Oct;88(4):637–648. doi: 10.1016/0091-6749(91)90158-k. [DOI] [PubMed] [Google Scholar]
  6. Brown M. A., Pierce J. H., Watson C. J., Falco J., Ihle J. N., Paul W. E. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 1987 Aug 28;50(5):809–818. doi: 10.1016/0092-8674(87)90339-4. [DOI] [PubMed] [Google Scholar]
  7. Corry D. B., Folkesson H. G., Warnock M. L., Erle D. J., Matthay M. A., Wiener-Kronish J. P., Locksley R. M. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med. 1996 Jan 1;183(1):109–117. doi: 10.1084/jem.183.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Sanctis G. T., Merchant M., Beier D. R., Dredge R. D., Grobholz J. K., Martin T. R., Lander E. S., Drazen J. M. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat Genet. 1995 Oct;11(2):150–154. doi: 10.1038/ng1095-150. [DOI] [PubMed] [Google Scholar]
  9. Drazen J. M., Gaston B., Shore S. A. Chemical regulation of pulmonary airway tone. Annu Rev Physiol. 1995;57:151–170. doi: 10.1146/annurev.ph.57.030195.001055. [DOI] [PubMed] [Google Scholar]
  10. Ebisawa M., Yamada T., Bickel C., Klunk D., Schleimer R. P. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol. 1994 Sep 1;153(5):2153–2160. [PubMed] [Google Scholar]
  11. Empey D. W., Laitinen L. A., Jacobs L., Gold W. M., Nadel J. A. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976 Feb;113(2):131–139. doi: 10.1164/arrd.1976.113.2.131. [DOI] [PubMed] [Google Scholar]
  12. Flint K. C., Leung K. B., Pearce F. L., Hudspith B. N., Brostoff J., Johnson N. M. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci (Lond) 1985 Apr;68(4):427–432. doi: 10.1042/cs0680427. [DOI] [PubMed] [Google Scholar]
  13. Foster P. S., Hogan S. P., Ramsay A. J., Matthaei K. I., Young I. G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996 Jan 1;183(1):195–201. doi: 10.1084/jem.183.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Galli S. J. New concepts about the mast cell. N Engl J Med. 1993 Jan 28;328(4):257–265. doi: 10.1056/NEJM199301283280408. [DOI] [PubMed] [Google Scholar]
  15. Geha R. S. Regulation of IgE synthesis in humans. J Allergy Clin Immunol. 1992 Aug;90(2):143–150. doi: 10.1016/0091-6749(92)90064-9. [DOI] [PubMed] [Google Scholar]
  16. Ghildyal N., Friend D. S., Freelund R., Austen K. F., McNeil H. P., Schiller V., Stevens R. L. Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J Immunol. 1994 Sep 15;153(6):2624–2630. [PubMed] [Google Scholar]
  17. Goldstein R. A., Paul W. E., Metcalfe D. D., Busse W. W., Reece E. R. NIH conference. Asthma. Ann Intern Med. 1994 Nov 1;121(9):698–708. doi: 10.7326/0003-4819-121-9-199411010-00011. [DOI] [PubMed] [Google Scholar]
  18. Gordon J. R., Galli S. J. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med. 1994 Dec 1;180(6):2027–2037. doi: 10.1084/jem.180.6.2027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gounni A. S., Lamkhioued B., Delaporte E., Dubost A., Kinet J. P., Capron A., Capron M. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1214–1216. doi: 10.1016/0091-6749(94)90334-4. [DOI] [PubMed] [Google Scholar]
  20. Gounni A. S., Lamkhioued B., Ochiai K., Tanaka Y., Delaporte E., Capron A., Kinet J. P., Capron M. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature. 1994 Jan 13;367(6459):183–186. doi: 10.1038/367183a0. [DOI] [PubMed] [Google Scholar]
  21. Hamann K. J., Strek M. E., Baranowski S. L., Munoz N. M., Williams F. S., White S. R., Vita A., Leff A. R. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am J Physiol. 1993 Sep;265(3 Pt 1):L301–L307. doi: 10.1152/ajplung.1993.265.3.L301. [DOI] [PubMed] [Google Scholar]
  22. Holgate S. Mediator and cytokine mechanisms in asthma. Thorax. 1993 Feb;48(2):103–109. doi: 10.1136/thx.48.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Holtzman M. J., Fabbri L. M., O'Byrne P. M., Gold B. D., Aizawa H., Walters E. H., Alpert S. E., Nadel J. A. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis. 1983 Jun;127(6):686–690. doi: 10.1164/arrd.1983.127.6.686. [DOI] [PubMed] [Google Scholar]
  24. Howarth P. H., Bradding P., Quint D., Redington A. E., Holgate S. T. Cytokines and airway inflammation. Ann N Y Acad Sci. 1994 May 28;725:69–82. doi: 10.1111/j.1749-6632.1994.tb39791.x. [DOI] [PubMed] [Google Scholar]
  25. Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J. S., Gleich G. J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991 Sep 1;174(3):745–748. doi: 10.1084/jem.174.3.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lee T. H., Crea A. E., Gant V., Spur B. W., Marron B. E., Nicolaou K. C., Reardon E., Brezinski M., Serhan C. N. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis. 1990 Jun;141(6):1453–1458. doi: 10.1164/ajrccm/141.6.1453. [DOI] [PubMed] [Google Scholar]
  27. Leung D. Y., Martin R. J., Szefler S. J., Sher E. R., Ying S., Kay A. B., Hamid Q. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med. 1995 Jan 1;181(1):33–40. doi: 10.1084/jem.181.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Levy B. D., Bertram S., Tai H. H., Israel E., Fischer A., Drazen J. M., Serhan C. N. Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids. 1993 Dec;28(12):1047–1053. doi: 10.1007/BF02537069. [DOI] [PubMed] [Google Scholar]
  29. Lilly C. M., Martins M. A., Drazen J. M. Peptidase modulation of vasoactive intestinal peptide pulmonary relaxation in tracheal superfused guinea pig lungs. J Clin Invest. 1993 Jan;91(1):235–243. doi: 10.1172/JCI116176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. MacPhee M., Chepenik K. P., Liddell R. A., Nelson K. K., Siracusa L. D., Buchberg A. M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell. 1995 Jun 16;81(6):957–966. doi: 10.1016/0092-8674(95)90015-2. [DOI] [PubMed] [Google Scholar]
  31. Martin T. R., Takeishi T., Katz H. R., Austen K. F., Drazen J. M., Galli S. J. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest. 1993 Mar;91(3):1176–1182. doi: 10.1172/JCI116277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Maurer D., Fiebiger E., Reininger B., Wolff-Winiski B., Jouvin M. H., Kilgus O., Kinet J. P., Stingl G. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med. 1994 Feb 1;179(2):745–750. doi: 10.1084/jem.179.2.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. McNeil H. P., Reynolds D. S., Schiller V., Ghildyal N., Gurley D. S., Austen K. F., Stevens R. L. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11174–11178. doi: 10.1073/pnas.89.23.11174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Moqbel R., Hamid Q., Ying S., Barkans J., Hartnell A., Tsicopoulos A., Wardlaw A. J., Kay A. B. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med. 1991 Sep 1;174(3):749–752. doi: 10.1084/jem.174.3.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Murakami M., Kudo I., Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem. 1993 Jan 15;268(2):839–844. [PubMed] [Google Scholar]
  36. Murakami M., Kudo I., Suwa Y., Inoue K. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur J Biochem. 1992 Oct 1;209(1):257–265. doi: 10.1111/j.1432-1033.1992.tb17284.x. [DOI] [PubMed] [Google Scholar]
  37. Nadel J. A. Biology of mast cell tryptase and chymase. Ann N Y Acad Sci. 1991;629:319–331. doi: 10.1111/j.1749-6632.1991.tb37986.x. [DOI] [PubMed] [Google Scholar]
  38. Owen W. F., Jr, Rothenberg M. E., Silberstein D. S., Gasson J. C., Stevens R. L., Austen K. F., Soberman R. J. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med. 1987 Jul 1;166(1):129–141. doi: 10.1084/jem.166.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Paré P. D., Bai T. R. The consequences of chronic allergic inflammation. Thorax. 1995 Apr;50(4):328–332. doi: 10.1136/thx.50.4.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Peters S. P. Mast cells and histamine in asthma. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):642–646. doi: 10.1016/s0091-6749(05)80230-1. [DOI] [PubMed] [Google Scholar]
  41. Rand T. H., Silberstein D. S., Kornfeld H., Weller P. F. Human eosinophils express functional interleukin 2 receptors. J Clin Invest. 1991 Sep;88(3):825–832. doi: 10.1172/JCI115383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Robinson D. S., Durham S. R., Kay A. B. Cytokines. 3. Cytokines in asthma. Thorax. 1993 Aug;48(8):845–853. doi: 10.1136/thx.48.8.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  44. Rothenberg M. E., Owen W. F., Jr, Silberstein D. S., Woods J., Soberman R. J., Austen K. F., Stevens R. L. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 1988 Jun;81(6):1986–1992. doi: 10.1172/JCI113547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sanderson C. J. Interleukin-5, eosinophils, and disease. Blood. 1992 Jun 15;79(12):3101–3109. [PubMed] [Google Scholar]
  46. Smith L. J. The role of platelet-activating factor in asthma. Am Rev Respir Dis. 1991 May;143(5 Pt 2):S100–S102. doi: 10.1164/ajrccm/143.5_Pt_2.S100. [DOI] [PubMed] [Google Scholar]
  47. Stevens R. L., Friend D. S., McNeil H. P., Schiller V., Ghildyal N., Austen K. F. Strain-specific and tissue-specific expression of mouse mast cell secretory granule proteases. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):128–132. doi: 10.1073/pnas.91.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wanner A., Abraham W. M., Douglas J. S., Drazen J. M., Richerson H. B., Ram J. S. NHLBI Workshop Summary. Models of airway hyperresponsiveness. Am Rev Respir Dis. 1990 Jan;141(1):253–257. doi: 10.1164/ajrccm/141.1.253. [DOI] [PubMed] [Google Scholar]
  49. Woolley K. L., Adelroth E., Woolley M. J., Ellis R., Jordana M., O'Byrne P. M. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur Respir J. 1994 Sep;7(9):1576–1584. doi: 10.1183/09031936.94.07091576. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES